Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 70/100

Failure Rate

26.9%

7 terminated/withdrawn out of 26 trials

Success Rate

68.2%

-18.3% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

93%

14 of 15 completed trials have results

Key Signals

14 with results7 terminated

Enrollment Performance

Analytics

N/A
12(50.0%)
Phase 2
6(25.0%)
Phase 1
6(25.0%)
24Total
N/A(12)
Phase 2(6)
Phase 1(6)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (26)

Showing 20 of 26 trials
NCT02412228Phase 2Completed

Ixazomib, Cyclophosphamide and Dexamethasone for Multiple Myeloma

Role: collaborator

NCT01351389Not ApplicableCompleted

Brief Interventions in the Emergency Department for Alcohol and HIV/Sexual Risk

Role: collaborator

NCT00447122Phase 1Terminated

BrUOG-PA-209: Lapatinib and Gemcitabine for Metastatic Pancreaticobiliary Cancer

Role: collaborator

NCT00740181Phase 2Terminated

Decitabine, Cytarabine, GCSF for Refractory AML/MDS

Role: collaborator

NCT01212627Phase 1Terminated

Ridaforolimus With Cetuximab: Adv Non-Small Cell Lung, Colorectal, Head & Neck Cancer

Role: collaborator

NCT01656460Not ApplicableCompleted

Stereotactic Body Radiation for Consolidation After Standard Chemoradiation for Stage 3 Lung Cancer

Role: collaborator

NCT01363843Phase 2Completed

Complete Neoadjuvant Treatment for REctal Cancer (CONTRE)

Role: collaborator

NCT00717756Phase 2Completed

Lenalidomide for Advanced Hepatocellular Cancer:A Phase II Trial

Role: collaborator

NCT01744353Phase 1Completed

BrUOG 278: FOLFOX-A For Pancreatic Cancer A Brown University Oncology Research Group Study

Role: collaborator

NCT01057277Phase 1Terminated

RAD001, Cisplatin and Concurrent Radiation for Locally Advanced, Inoperable Head and Neck Cancer

Role: collaborator

NCT02579915Not ApplicableCompleted

Developing a Low-Intensity Primary Care Intervention for Anxiety Disorders (AIM-PC)

Role: collaborator

NCT03099889Not ApplicableUnknown

WHISH-2-Prevent Heart Failure

Role: lead

NCT00462865Phase 2Terminated

Trial of Chemotherapy and Avastin as Treatment for Women With Breast Cancer at High Risk for Relapse

Role: collaborator

NCT02266446Not ApplicableCompleted

Developing a Low-Intensity Primary Care Intervention for Anxiety Disorders

Role: collaborator

NCT01237561Not ApplicableCompleted

Translating The GOLD COPD Guidelines Into Primary Care Practice

Role: lead

NCT01387945Not ApplicableCompleted

Pilot Study of Home Blood Pressure Control Program (eBP Control)

Role: lead

NCT01542671Not ApplicableCompleted

Tailored Lifestyle Intervention in Obese Adults Within Primary Care Practice - Choose to Lose

Role: lead

NCT01119794Phase 2Terminated

Ofatumumab and Bortezomib for Patients With Low-grade B-cell Non-hodgkin Lymphoma That Relapse After Rituximab

Role: collaborator

NCT00004826Not ApplicableCompleted

Study of Clozapine for the Treatment of Psychosis in Patients With Idiopathic Parkinson's Disease

Role: lead

NCT00787852Phase 1Terminated

A Study of Dasatinib With Concurrent Chemoradiation for Stage III Non-Small Cell Lung Cancer (NSCLC)

Role: collaborator